Drug profile · INN
trientine tetrahydrochloride
CUVRIOR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trientine tetrahydrochloride (CUVRIOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN trientine tetrahydrochloride
Brand CUVRIOR
Route ORAL
Formulation TABLET
Frequently asked questions
What is trientine tetrahydrochloride?
trientine tetrahydrochloride (CUVRIOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trientine tetrahydrochloride?
CUVRIOR is a marketed brand name for trientine tetrahydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trientine tetrahydrochloride?
trientine tetrahydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.